Literature DB >> 3882283

Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.

M Gheorghiu, D Mouton, H Lecoeur, M Lagranderie, J C Mevel, G Biozzi.   

Abstract

The resistance to Mycobacterium bovis (BCG) of lines of mice selected for high (H) or low (L) antibody responsiveness was estimated from the rate of BCG multiplication in the organs. During the first 2 weeks after i.v. infection with 5 X 10(6) CFU, BCG multiplied faster in the spleens of H than of L mice. Afterwards there was a more drastic reduction of viable BCG counts in H mice than in L mice so that the residual BCG counts were significantly lower in H mice than in L mice, not only in the spleen but also in the liver and lungs. On the 14th day of infection, the spleen and liver enlargement and the increase of phagocytic activity were similar in the two lines, suggesting an identical T lymphokine release. In contrast with BCG, during the first 2 weeks after infection with 7 X 10(5) CFU, M. tuberculosis (H37Rv) multiplied in the spleens of L mice at a similar or a slightly faster rate than in the spleens of H mice. On the 4th week, the viable H37Rv counts were reduced in H mice whereas L mice did not survive the infection. In mice vaccinated with BCG 5 months before virulent challenge, the multiplication of H37Rv was inhibited in the H and L lines. The protective effect of BCG is therefore stronger in L mice taking into account their higher innate susceptibility to H37Rv. This might be due to the higher level of living BCG found in L mice at the time of challenge.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882283      PMCID: PMC1577178     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  [Granulopectic activity of the reticuloendothelial system in experimental tuberculosis in mice].

Authors:  G BIOZZI; B BENACERRAF; F GRUMBACH; B N HALPERN; J LEVADITI; N RIST
Journal:  Ann Inst Pasteur (Paris)       Date:  1954-09

Review 2.  Genetics of immunoresponsiveness to natural antigens in the mouse.

Authors:  G Biozzi; D Mouton; O A Sant'Anna; H C Passos; M Gennari; M H Reis; V C Ferreira; A M Heumann; Y Bouthillier; O M Ibanez; C Stiffel; M Siqueira
Journal:  Curr Top Microbiol Immunol       Date:  1979       Impact factor: 4.291

3.  Immunopotentiation with BCG. I. Immune response to different strains and preparations.

Authors:  G B Mackaness; D J Auclair; P H Lagrange
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

4.  Mechanisms in the in vivo release of lymphokines: relationship of high and low responsiveness to other parameters of the immune response.

Authors:  R Neta; S B Salvin
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

5.  Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains.

Authors:  M Gheorghiu; P H Lagrange
Journal:  Ann Immunol (Paris)       Date:  1983 Jan-Feb

6.  Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice.

Authors:  P Gros; E Skamene; A Forget
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  Genetic control of resistance to Salmonella typhimurium infection in high and low antibody responder mice.

Authors:  J E Plant; A A Glynn
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

8.  Immunopathology of BCG infection in genetically resistant and susceptible mouse strains.

Authors:  M Pelletier; A Forget; D Bourassa; P Gros; E Skamene
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  The relevance to protection of three forms of delayed skin-test response evoked by m. leprae and other mycobacteria in mice. Correlation with the classical work in the guinea-pig.

Authors:  G A Rook; J L Stanford
Journal:  Parasite Immunol       Date:  1979       Impact factor: 2.280

10.  The protective effect in bank voles of some strains of BCG.

Authors:  A Ladefoged; K Bunch-Christensen; J Guld
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  1 in total

Review 1.  Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.

Authors:  A Glatman-Freedman; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.